Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia
Clinical trial NCT03825744 · COMPLETED
Trial details
- NCT number
- NCT03825744
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-05
- Primary completion
- 2024-07-03
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.